Evidence map›Paper›PMID 42177419›Full record

ArticleBMC pregnancy and childbirth2026

Placental mitochondrial DNA mutation-related oxidative stress underlies subsequent risk of adverse prognosis in sFGR twins.

Nana Huang, Yun Zhi, Hai Jiang, Xiaoli Gong, Jing Yang, Xueju Wang, Luyao Li, Pengbo Yuan, Yuan Wei, Yangyu Zhao

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nana Huang *Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Yun Zhi *School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
Hai JiangDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Xiaoli GongDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Jing YangDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Xueju WangDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Luyao LiDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Pengbo YuanDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Yuan WeiDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China. weiyuanbysy@163.com.
Yangyu ZhaoDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China. zhaoyangyu@bjmu.edu.cn.

Funding

China Postdoctoral Science foundation 2024M760149National Natural Science Foundation of China 82171661National Natural Science Foundation of China 82502060Natural Science Foundation of Beijing Municipality 7212133Special fund of National Clinical Key Specialty Construction Program, P. R. China 2024
6 · The paper itself

Abstract

backgroundSelective fetal growth restriction (sFGR), a serious complication of monochorionic diamniotic (MCDA) twin pregnancies, typically results from unequal placental sharing, especially in type II sFGR. This condition is associated with an increased risk of intrauterine death and adverse neurological outcomes in one of the twin fetuses. Mitochondria play an important role in fetal development and mitochondrial DNA (mtDNA) mutations have been implicated in the pathogenesis of singleton FGR. Mutations in the mtDNA can lead tomitochondrial dysfunction, oxidative stress, and apoptosis. However, the role of increased placental mtDNA mutations in the pathogenesis of sFGR and their potential association with fetal growth and nervous system development remain unclear.

methodsIn this study, we characterized and compared the mtDNA mutation rate (MMR) in placentas from eight pairs of type II sFGR twins and eight pairs of uncomplicated MCDA twin controls (MCDA-C). Furthermore, peripheral blood mtDNA from the mothers of both the sFGR and MCDA-C twins was sequenced to determine the differences in mtDNA heteroplasmy between the mothers and twins. The overall MMR and mutation frequencies of individual genes were analyzed separately. Mitochondrial damage, oxidative stress, and apoptosis in the placenta were investigated by immunohistochemistry. In addition, correlations between MMR, birth weight, gestational age, and brain injury were evaluated to investigate the relationship between mitochondrial defects and clinical outcomes.

resultsWhole mitochondrial genome sequencing identified a significantly higher MMR in sFGR placentas than in MCDA-C placentas, especially in respiratory chain genes (MT-ND3, MT-CYB, complex III, and complex V). Maternal peripheral blood MMR did not differ significantly between sFGR and MCDA-C groups. However, analysis of mtDNA heteroplasmy revealed a significantly greater mother-twin heteroplasmy difference in sFGR pairs than in MCDA-C pairs. Immunohistochemical staining showed increased PARKIN-mitochondria colocalization, 8-OHdG and cleaved caspase 3 signals in sFGR placentas, particularly in placentas from growth-restricted smaller twins (sFGR-S), suggesting increased mitochondrial damage, cellular oxidative stress, and apoptosis. In the correlation analysis, the placental MMR was negatively correlated with birth weight and gestational age at delivery. Notably, the incidence of fetal brain injury, especially periventricular leukomalacia (PVL), was higher in sFGR twins and was positively associated with the MMR.

conclusionsPlacental mtDNA mutations and related oxidative stress are associated with adverse intrauterine environments in sFGR twins and may be associated with a higher frequency of fetal brain injury.

Indexed as

DNA, MitochondrialFetal Growth RetardationMutationOxidative StressPlacentaPregnancy, TwinAdultApoptosisBirth WeightCase-Control StudiesFemaleHeteroplasmyHumansInfant, NewbornPregnancyPrognosisDNA, MitochondrialBirth weightFetal brain injurymtDNA mutation rateOxidative stressPlacentaSelective fetal growth restriction

Identifiers

PMID42177419
PMCPMC13374154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.